Masterworks.io vs MDAlgorithms.com

Invest in the world’s most valuable paintings.

For the first time ever, Masterworks.io is allowing investors to buy and
trade shares in great works of art.

Blue-chip fine art has been a superior risk-adjusted asset class for decades, outperforming the S&P 500 by 250% since the year 2000 with low degrees of volatility. However, these great works of art generally cost more than $2 million per painting, making them available only to the ultra- wealthy.

Masterworks takes balance sheet risk to purchase great works of art by collaborating with Christies, Sothebys, and Phillips. After purchasing a painting, we place it in an LLC and file it with the SEC to go public. This allows institutions, accredited and non-accredited investors to purchase shares of multi-million dollar, investment grade artwork.

Through the development of a trading platform that we plan to release in 2019, investors will be able to buy and trade shares in works of art just as they would with companies on the stock market.

Location: New York, United States

Mobile image analysis and Artificial intelligence for people with Acne.

MDAlgorithms developed a Mobile App platform to digitally disrupt skin health and beauty markets. It's MDacne mobile application uses image analysis and artificial intelligence (AI) for the assessment, treatment monitoring and user engagement of people with Acne. Starting with a quick Selfie, the app builds for people with Acne a customized daily routine, complete with product suggestions, fun video tutorials and daily tips and reminders. MDacne monitors skin improvement providing Carekit (Apple) integrated charts and B&A that can be easily shared with Family and Dermatologists. In 6 weeks after launch MDacne is teh #1 Acne app on Apple's Appstore and #100 Medical free IOS App in the US.